1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. INVENTIVA - ADR
Inventiva - ADR
XNAS: IVA
492.6K
XNAS Volume

XNAS 15 Oct, 2026 10:30 AM (EDT)

Portfolio

Alert

My Notes

Inventiva (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Inventiva (ADR) share price target, revenues, EPS, net income and more

Inventiva (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Inventiva (ADR) Dec-2025 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEUTRAL

    Quarterly Net Profit Inventiva (ADR) Dec-2025 Quarterly Net Profit is $0 Million which is growth of 0% YoY.

Inventiva - ADR, Earnings Report - Quarterly Results, standalone, All financials are in EUR Million and price data in USD
IndicatorGraphDec '25Jun '25Dec '24Jun '24Dec '23Jun '23Dec '22Jun '22Jun '21Mar '21Jun '20Mar '20Dec '19
Operating Rev.
--------0.10.10.10.1-
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
-----13.7-108.9-6.9
Operating Profit
------13.7-9.9-8.9-6.8
---------0-0-00-
Profit Before Tax
---------14.3-8.5-8.9-6.8-
Tax
--------0-0.3--
⌄
---------14.3-8.8-8.9-6.8-
Diluted NI Avail to Com Stockholders Ann.
---------14.3-8.8-8.9-6.8-
Basic EPS
---------0.4-0.2-0.2-0.2-
Diluted EPS After ExtraOrdinary
---------0.4-0.3-0.2-0.2-
Number Of Shares End
-----4242.142.138.738.638.72930.7
Net Income Continuing Discontinued Operations
---------14.3-8.8-8.9-6.8-
Normalized Income
---------14.6-9.9-8.6-6.6-
Interest Income
--------000-
Interest
--------0-0--
Net Interest Income
---------0--0--
EBIT
---------14.3-8.5-8.9-6.8-
EBITDA
---------14-8.2-8.5-6.5-
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
--------0.20.30.30.3-
Profit From Continuing Operations
---------14.3-8.8-8.9-6.8-
Normalized EBITDA
---------13.4-9.6-8.5-6.5-
*All financials are in EUR Million and price data in USD

Inventiva (ADR) competitor comparison and performance snapshot within industry

Inventiva (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEGATIVE

    Annual Revenue Inventiva (ADR) Dec-2025 Annual Revenue is $4 Million which is growth of -51.3% YoY.

  • NEGATIVE

    Annual Net Profit Inventiva (ADR) Dec-2025 Annual Net Profit is $-354 Million which is growth of -92.2% YoY.

Inventiva - ADR, Earnings Report - Annual Results, standalone, All financials are in EUR Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-28.3%
62.3%
 4.59.217.512.24.20.473.26.59.54.9
Cost Of Rev. Ann.
-
-
 -----------
Gross Profit Ann.
-
-
 -----------
Operating Exp. Ann.
-
-
 -137.4-103.2-120.1-69.2-56.327.335.934.22721.519.8
Operating Profit Ann.
-
-
 -132.9-94-102.7-57-52.1-26.9-28.9-31-20.5-12.1-14.9
-
-
 -30.6-11-4.2-0.3-0.10.20.1-0.10.30.50.5
Other Exp. Ann.
-
-
 ------6.9-1.5-2.3-0.4-1-0.6
PBT Ann.
-
-
 -354.1-183.9-109.8-54.3-49.3-33.6-30.2-33.4-20.6-12.6-15
Tax Ann.
-
-
 -0-0.3-0.60-0.40.3-3.4-5.5-6.2
⌄
-
-
 -354.1-184.2-110.4-54.3-49.6-33.6-30.2-33.6-17.2-7.1-8.8
Diluted NI Avail to Com Stockholders Ann.
-
-
 -354.1-184.2-110.4-54.3-49.6-33.6-30.2-33.6-17.2-7.1-8.8
EPS Ann.
-
-
 -1.9-3.1-2.4-1.3-1.3-1-1.3-1.6-1.1-0.7-0.9
Diluted EPS Ann.
-
-
 -1.9-3.1-2.4-1.3-1.3-1-1.3-1.6-1.1-0.7-0.9
Number Of Shares End
-
-
 ---42.1--30.722.216.415.7-
Total Exp. Ann.
-
-
 -----27.335.934.22721.519.8
Net Income Continuing Discontinued Operations Ann.
-
-
 -354.1-184.2-110.4-54.3-49.6-33.6-30.2-33.6-17.2-7.1-8.8
Normalized Income Ann.
-
-
 -192.1-122.5-106.9-51.4-51.5-30.4-27.4-31.6-17.1-6.4-8.4
Interest Income Ann.
93.5%
70.7%
 2.91.110.40.10.20.20.10.30.20.2
Interest Ann.
-
-
 -----0.1000
EBITDA Ann.
-
-
 -320.3-167.7-103-52.3-49-31.9-28.8-31.2-19.5-11.1-11.3
Reconciled Cost Of Rev. Ann.
-
-
 -----------
Reconciled Depr. Ann.
23.5%
11%
 3.25.22.61.7-1.31.91.62.31.41.71.3
Profit From Continuing Operations Ann.
-
-
 -354.1-184.2-110.4-54.3-49.6-33.6-30.2-33.6-17.2-7.1-8.8
Normalized EBITDA Ann.
-
-
 -127.1-88-101.1-54.8-51.9-24.8-27.2-28.8-18.8-9.9-13.1
*All financials are in EUR Million and price data in USD
Total Rev. Ann.
1Y CHG
-51.1%
2Y CAGR
-49.3%
3Y CAGR
-28.3%
5Y CAGR
62.3%
7Y CAGR
5%
10Y CAGR
-0.8%
Total Revenue Annual is falling faster than historical averages.

Inventiva (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Inventiva (ADR) Dec-2025 Total Shareholders Fund is $-29 Million which is growth of 73.3% YoY.

  • POSITIVE

    Total Assets Inventiva (ADR) Dec-2025 Total Assets is $250 Million which is growth of 109.7% YoY.

Inventiva - ADR, Balance Sheet, standalone, All financials are in EUR Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
29.1%
12.4%
249.511969.6116122138.95779.874.448.960.6
⌄
58%
58.6%
278225.6101.670.533.127.715.618.210.413.117.8
⌄
-
-
-28.5-106.7-3245.588.9111.241.461.66435.742.8
Total Capitalization Ann.
-
-
-1.7-60.3-4.174.197.6121.341.461.764.236.243.3
Tangible Assets Ann.
-
-
-28.7-106.7-32.644.988.1110.340.260.162.233.740.4
Working Capital Ann.
-
-
-----119.13556.658.432.720.9
Invested Capital Ann.
-
-
-----121.341.561.864.536.443.5
Tangible Book Value Ann.
-
-
-28.7-106.7-32.644.988.1110.340.260.162.233.740.4
Borrowings Ann.
-
-
-----10.10.10.20.50.60.7
Net Debt Ann.
-
-
-----------
Share Issued Ann.
66.2%
38%
193.295.852.242.140.938.630.722.216.415.715.7
Number Of Shares End
-
-
---42.1--30.722.216.415.7-
*All financials are in EUR Million and price data in USD
Total Assets Ann.
1Y CHG
109.7%
2Y CAGR
89.3%
3Y CAGR
29.1%
5Y CAGR
12.4%
7Y CAGR
17.7%
10Y CAGR
15.2%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-35.9%
2Y CAGR
24.2%
3Y CAGR
36.1%
5Y CAGR
41%
7Y CAGR
26.3%
10Y CAGR
25.8%
Total Current Liabilities Annual Cr is falling faster than historical averages.

Inventiva (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share Inventiva (ADR) Book Value Per Share is $-0 which is growth of 84.0% YoY.

  • NEUTRAL

    ROE Inventiva (ADR) ROE is 0% which is growth of 0% YoY.

Inventiva - ADR, Ratios, standalone, All financials are in EUR Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--195.42%-119.02%--38.05%-34.33%-44.19%-43.61%-27.96%-12.88%-13.20%
ROE Ann. %
-
-
---1,642.63%--49.62%-44.06%-58.68%-53.53%-34.55%-17.95%-18.72%
ROIC %
-
-
-----------
OPM Ann. %
-
-
-2,964.15%-1,021.84%-587.43%-468.32%-1,242.87%-7,225.54%-412.86%-969.57%-313.86%-127.56%-305.14%
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
-0.10.2-00.100.10.20.1
Working Capital Turnover Ann.
-
-
-----0.20.10.10.30.2
Quick Ratio Ann.
-
-
-0.90.9-4.79.13.54.67.53.83.5
Current Ratio Ann.
-
-
-0.91-5.19.63.54.87.64.83.7
Interest Coverage Ratio Ann.
-
-
--14.1-20.2--356.1-508.4-10,071.3-8,339.8-3,881.2-1,662.8-2,477.8
LT Debt To Equity Ann.
-
-
----0.10.100
*All financials are in EUR Million and price data in USD

Inventiva (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Inventiva (ADR) Dec-2025 Cash From Operating Activity is $-105 Million which is growth of -22.1% YoY.

  • NEGATIVE

    Net Cash Flow Inventiva (ADR) Dec-2025 Net Cash Flow is $3 Million which is growth of -95.3% YoY.

Inventiva - ADR, Cash Flow, standalone, All financials are in EUR Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
-104.9-85.9-81.6-44.9-47.6-30.6-28.4-34.2-17-14.9-14
-
-
-133.28.7-7.78.9-1.8-8.6-0.8-0.46.217.218.9
86.3%
16.7%
241.3145.629.137.325.5111.78.432.345-0.10.6
Cash Plus Cash Eqv. End Of Year Ann.
4.6%
-1.2%
99.396.626.986.786.6105.735.856.759.124.922.6
Net Increase In Cash Plus Cash Eqv.s Ann.
38.7%
-46.4%
3.268.4-60.31.2-2472.5-20.9-2.434.22.35.5
Cash Plus Cash Eqv. Begin Of Year Ann.
3.7%
22%
96.626.986.786.6105.735.856.759.124.922.617.1
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
-0.3-0.3-0.5-0.6-0.5-0.3-0.1-0.6-0.4-0.2-1
Issuance Of Capital Stock Ann.
186.2%
15.2%
206.457.328.18.825.5101.88.732.545.2
Issuance Of Debt Ann.
-
-
24.9--10---0.10.7
Repayment Of Debt Ann.
-
-
-6-5-4.1-1.8-0-0.1-0.2-0.3-0.2-0.2-0.1
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-105.4-86.3-82.2-45.5-48.2-30.9-28.5-34.8-17.4-15.1-15
*All financials are in EUR Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
65.7%
2Y CAGR
188%
3Y CAGR
86.3%
5Y CAGR
16.7%
7Y CAGR
33.3%
10Y CAGR
82.2%
Cash from Financing Annual Activity growth is stable compared to historical averages.